SEC Filings TLDR

Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 9.0% of the Ordinary Shares of Quoin Pharmaceuticals Ltd. The filing, dated October 24, 2025, indicates that t...

D. E. Shaw & Co., L.P., D. E. Shaw & Co., L.L.C., and David E. Shaw have reported a 5.1% ownership in Keros Therapeutics, Inc. as of October 20, 2025. The shares are held through various entities managed by D. E. Shaw & Co., L.P. and D. E. Shaw & Co., L.L.C. David E. Shaw, as the President and sole shareholder of the g...

Commodore Capital LP, along with Commodore Capital Master LP, Michael Kramarz, and Robert Egen Atkinson, filed a Schedule 13G with the SEC, disclosing their ownership in Alto Neuroscience, Inc. As of October 20, 2025, the group beneficially owns 3,190,267 shares of Common Stock, representing 9.8% of the outstanding sha...

CVI Investments, Inc. and Heights Capital Management, Inc. have filed a Schedule 13G with the SEC, reporting beneficial ownership of 9.9% of the common stock of Citius Pharmaceuticals, Inc. The filing indicates that Heights Capital Management, Inc. serves as the investment manager for CVI Investments, Inc. and may exer...

CVI Investments, Inc. and Heights Capital Management, Inc. have filed a Schedule 13G with the SEC, reporting beneficial ownership of 9.9% of the common stock of Citius Pharmaceuticals, Inc. The filing indicates that Heights Capital Management, Inc. serves as the investment manager for CVI Investments, Inc. and may exer...

CRCM LP, along with its affiliated entities, has filed a Schedule 13G with the SEC, disclosing an 8.2% ownership stake in ALT5 Sigma Corp. The filing, dated October 27, 2025, indicates that CRCM LP beneficially owns 8,970,883 shares of the company's common stock. The filing also includes other entities such as CRCM LLC...

Varun Singh Amar Singh has filed a Schedule 13G with the SEC regarding AIRWA INC. The filing indicates that Varun Singh Amar Singh, a citizen of India, does not beneficially own any shares of AIRWA INC.'s common stock. The filing is made under Rule 13d-1(c) and certifies that the securities were not acquired for the pu...

Commodore Capital LP, along with Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz, filed a Schedule 13G on October 27, 2025, disclosing a 9.8% ownership in Alto Neuroscience, Inc. The filing indicates that Commodore Capital LP beneficially owns 3,190,267 shares of Common Stock, including shares ac...

CRCM LP, along with its affiliates, has filed a Schedule 13G indicating the acquisition of an 8.2% stake in ALT5 Sigma Corp. The filing, dated October 27, 2025, reveals that CRCM LP and its related entities collectively own 8,970,883 shares of Common Stock, valued at approximately $20.27 million. The shares are held di...

Varun Singh Amar Singh, a citizen of India, has filed a Schedule 13G with the SEC, reporting no beneficial ownership of shares in AIRWA INC. The filing indicates that Varun Singh Amar Singh holds 0 shares of the company's common stock, with no sole or shared voting or dispositive power. The filing is made under Rule 13...

JPMorgan Chase & Co filed a Schedule 13G form disclosing its 5% ownership in WillScot Holdings Corporation. As of September 30, 2025, JPMorgan Chase & Co beneficially owns 9,105,688 shares of WillScot's common stock, representing a 5% ownership stake. The filing indicates that JPMorgan Chase & Co has sole voting power ...

JPMorgan Chase & Co has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in Warby Parker Inc. As of September 30, 2025, JPMorgan Chase & Co beneficially owns 7,308,806 shares of Class A Common Stock, representing 6.9% of the total shares outstanding. This marks a significant increase from thei...

Blossom Fountain Limited, Herobright Limited, and Galaxy Entertainment Group Limited have jointly filed a Schedule 13G with the SEC, disclosing their collective ownership of 5,200,000 shares of Wynn Resorts Ltd's common stock, representing 5.0% of the outstanding shares. The filing was triggered by a decrease in the to...

Norges Bank has filed a Schedule 13G with the SEC, disclosing an increased ownership of 5.3% in Upstream Bio Inc. The filing indicates that Norges Bank now holds 2,882,647 shares of the company's common stock, representing a significant increase from previous holdings. The shares are held on behalf of the Government of...

JPMorgan Chase & Co and its subsidiary, JPMorgan Chase Funding Inc., have filed a Schedule 13G with the SEC, disclosing their ownership in Sky Quarry Inc. As of September 30, 2025, JPMorgan Chase & Co owns 2,249,882 shares of Sky Quarry Inc.'s common stock, representing 9.6% of the total shares outstanding. The shares ...

SciSparc Ltd. has filed a Schedule 13G with the SEC, disclosing its beneficial ownership of 490,751 shares of common stock in N2OFF, Inc., representing 18.3% of the total outstanding shares. The filing, made under Rule 13d-1(c), indicates that the shares were not acquired for the purpose of influencing the control of N...

Squadron Master Fund LP, Squadron Capital Management, LLC, Matthew Sesterhenn, and William Blank have filed a Schedule 13G to report their ownership in NextCure, Inc. Squadron Master Fund LP owns 5.8% of the common stock, while Squadron Capital Management, LLC, Matthew Sesterhenn, and William Blank each own 6.5%. The f...

SciSparc Ltd., based in Israel, has filed a Schedule 13G to report its beneficial ownership of 490,751 shares of common stock in N2OFF, Inc., representing 18.3% of the total outstanding shares as of October 20, 2025. The filing indicates that SciSparc Ltd. holds sole voting and dispositive power over these shares. The ...

JPMorgan Chase & Co. and JPMorgan Chase Funding Inc. have filed a Schedule 13G with the SEC, reporting a 9.6% ownership in Sky Quarry Inc. The filing indicates that both entities hold 2,249,882 shares of common stock, with sole voting and dispositive power. The filing is made under Rule 13d-1(d) and certifies that the ...

JPMorgan Chase & Co. has filed a Schedule 13G with the SEC, disclosing a 5% ownership stake in WillScot Holdings Corporation. The filing indicates that JPMorgan Chase & Co. beneficially owns 9,105,688 shares of WillScot's common stock, with sole voting power over 8,427,731 shares and sole dispositive power over 9,080,9...

JPMorgan Chase & Co. has filed a Schedule 13G with the SEC, reporting a 6.9% ownership in Warby Parker Inc. The filing indicates that JPMorgan Chase & Co. beneficially owns 7,308,806 shares of Class A Common Stock, with sole voting power over 4,744,945 shares and shared voting power over 189 shares. The filing also det...

Tang Capital Management LLC (TCM) has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in Immunocore Holdings plc. As of October 24, 2025, TCM beneficially owns 2,605,608 American Depositary Shares (ADSs), representing 5.2% of the outstanding ordinary shares. This marks an increase of 500,000 ...

UBS Asset Management, through its distinct business unit O'Connor, has reported a 9.9% ownership in Electra Battery Materials Corp. The filing, made under Rule 13d-1(b), indicates that UBS Asset Management beneficially owns 9,278,996 common shares of the company. The shares are held in the ordinary course of business a...

Whitebox Advisors LLC and Whitebox General Partner LLC have filed a Schedule 13G amendment with the SEC, reporting a 9.9% ownership in Electra Battery Materials Corp. The filing indicates that as of October 22, 2025, the reporting entities beneficially own 9,271,572 common shares of the company. The shares are held by ...

Highbridge Capital Management LLC has filed a Schedule 13G with the SEC, disclosing its beneficial ownership of 9.9% of the common shares of Electra Battery Materials Corp. The filing indicates that Highbridge holds 9,291,272 common shares, representing 9.9% of the outstanding shares. The filing also mentions that High...